Characterization of a highly pathogenic SIVagm isolate. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Characterization of a highly pathogenic SIVagm isolate.

Symp Nonhum Primate Models AIDS. 1993 Sep 19-22;11:abstract no. 28. Unique Identifier : AIDSLINE PRIM11/94191621
Dapolito GA; Elkins WR; London WT; Goldstein S; Johnson PR; Hirsch VM; LID, NIAID, NIH, Rockville, MD 20852.


Abstract: SIV pathogenesis studies have been restricted primarily to viruses isolated from sooty mangabeys (SIVsm) or macaques (SIVmac) since these viruses induce immunodeficiency similar to human AIDS in inoculated macaques. In contrast, infection of macaques with SIV isolated from African green monkeys (SIVagm) generally results in transient viremia with no associated disease, leading some to suggest that SIVagm is nonpathogenic. However, we previously observed CD4 depletion and Mycobacterium infection in a pig-tailed macaque (Macaca nemestrina) inoculated with SIVagm isolated from a naturally infected vervet monkey (Cercopithecus pygerythrus). Terminally, virus was isolated from the spleen in CEMss cells, and this isolate was designated SIVagm9063. The goal of the present study was to characterize the pathogenic and molecular properties of this novel SIVagm strain. Pig-tailed macaques, rhesus macaques, and African green monkeys were inoculated intravenously with SIVagm9063. All three species became infected, however, only pig-tailed macaques developed an AIDS-like syndrome with a progressive decline in circulating CD4 lymphocytes. Three of these macaques were sacrificed within 1 year of inoculation due to opportunistic infections. In parallel studies, genomic DNA derived from the SIVagm9063 isolate was used to generate a lambda library and derive two infectious clones. Sequence analysis showed that this virus clustered with other vervet isolates but was genetically distinct. Progeny virus derived by transfection of either clone infected macaque PBMC and macrophages in culture and resulted in persistent infection in pig-tailed macaques. Although animal studies are preliminary, an early, persistent decline in CD4 cells in the blood suggest that these cloned viruses are representative of the parental strain in virulence. This study demonstrates that some SIVagm strains induce AIDS in experimentally-infected macaques and will provide a basis for studying host and virus specific factors in pathogenicity.
Keywords: Acquired Immunodeficiency Syndrome/MICROBIOLOGY Animal Antigens, CD4/BLOOD Cercopithecus aethiops/*MICROBIOLOGY DNA, Viral/ANALYSIS/GENETICS Genome, Viral Human Macaca mulatta/*MICROBIOLOGY Macaca nemestrina/*MICROBIOLOGY Simian Acquired Immunodeficiency Syndrome/IMMUNOLOGY/ *MICROBIOLOGY Species Specificity SIV/GENETICS/*ISOLATION & PURIF/*PATHOGENICITY T-Lymphocyte Subsets/IMMUNOLOGY Virulence ABSTRACTKWDacquiredimmunodeficiencysyndrome/microbiologyanimalantigens,cd4/bloodcercopithecusaethiops/KWDmicrobiologydna,viral/analysis/geneticsgenome,viralhumanmacacamulatta/KWDmicrobiologymacacanemestrina/KWDmicrobiologysimianacquiredimmunodeficiencysyndrome/immunology/KWDmicrobiologyspeciesspecificitysiv/genetics/KWDisolation&purif/KWDpathogenicityt-lymphocytesubsets/immunologyvirulenceabstract
940730
M9470897

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .